Trial Outcomes & Findings for Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease (NCT NCT03883217)

NCT ID: NCT03883217

Last Updated: 2026-03-16

Results Overview

The Functional Ambulation Profile (FAP) score is the gold standard for spatiotemporal gait parameter analysis. For this study, it will be mean calculated by participants walking on the Zeno walkway, which will measure the patient's physical measurements, step length, step time and degree of symmetry., dynamic base of support and the use of ambulatory aids are factored into the score. The Zeno instrumented walkway (PKMAS) is a 20-foot computerized walkway containing sensor pads. A full FAP (Functional Ambulation Profile) score is calculated by deducting points from a maximum score of 100 and the minimum is a 0, with points being subtracted based on deviations from normal gait patterns observed during a self-selected velocity walking trial; essentially, a higher score (closer to 100) indicates closer to normal gait function while a lower score (closer to 0) represents greater gait impairments. No subscales. This is reported as the mean of the two scores for each session aggregated.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

Throughout study completion, from 9 to 34 days.

Results posted on

2026-03-16

Participant Flow

Participant milestones

Participant milestones
Measure
Vibration Intervention First Arm
The vibration intervention first and then the no vibration intervention. The order of the intervention was being assessed.
No Vibration Intervention First Arm
The no vibration intervention session first and then the vibration intervention. The order of the intervention was being assessed.
Overall Study
STARTED
7
5
Overall Study
COMPLETED
7
5
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Vibration Intervention First Arm
n=7 Participants
The intervention session first and then the no vibration intervention. The order of the intervention was being assessed.
No Vibration Intervention First Arm
n=5 Participants
The no intervention session first and then the vibration intervention. The order of the intervention was being assessed.
Total
n=12 Participants
Total of all reporting groups
Age, Continuous
71.6 years
STANDARD_DEVIATION 6 • n=10 Participants
65.8 years
STANDARD_DEVIATION 7.9 • n=50 Participants
69.2 years
STANDARD_DEVIATION 7.1 • n=108 Participants
Sex: Female, Male
Female
2 Participants
n=10 Participants
2 Participants
n=50 Participants
4 Participants
n=108 Participants
Sex: Female, Male
Male
5 Participants
n=10 Participants
3 Participants
n=50 Participants
8 Participants
n=108 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=10 Participants
5 Participants
n=50 Participants
12 Participants
n=108 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
Asian
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
White
7 Participants
n=10 Participants
5 Participants
n=50 Participants
12 Participants
n=108 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=10 Participants
0 Participants
n=50 Participants
0 Participants
n=108 Participants
Region of Enrollment
United States
7 participants
n=10 Participants
5 participants
n=50 Participants
12 participants
n=108 Participants

PRIMARY outcome

Timeframe: Throughout study completion, from 9 to 34 days.

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The Functional Ambulation Profile (FAP) score is the gold standard for spatiotemporal gait parameter analysis. For this study, it will be mean calculated by participants walking on the Zeno walkway, which will measure the patient's physical measurements, step length, step time and degree of symmetry., dynamic base of support and the use of ambulatory aids are factored into the score. The Zeno instrumented walkway (PKMAS) is a 20-foot computerized walkway containing sensor pads. A full FAP (Functional Ambulation Profile) score is calculated by deducting points from a maximum score of 100 and the minimum is a 0, with points being subtracted based on deviations from normal gait patterns observed during a self-selected velocity walking trial; essentially, a higher score (closer to 100) indicates closer to normal gait function while a lower score (closer to 0) represents greater gait impairments. No subscales. This is reported as the mean of the two scores for each session aggregated.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
Functional Ambulation Profile (FAP) Score
99.2 FAP score on a scale
Standard Deviation 6
86.8 FAP score on a scale
Standard Deviation 6

PRIMARY outcome

Timeframe: Throughout study completion, from 9 to 34 days.

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The "Movement Disorder Society Unified Parkinson Disease Rating Scale" (MDS-UPDRS),will be used to assess the total burden of motor Parkinson Disease (PD) symptoms and impact on activities of daily living. There are four sections to this scale and all sections use a scale of 0-4 ratings: 0 (normal), 1 (slight), 2 (mild), 3 (moderate), and 4 (severe)lower scores are better and indicate less disability. Part II: 13 items about Activities of Daily Living, score range 0-52. Part III: 18 items PD motor signs, score range is 0-72, Each item has 0-4 ratings: 0 (normal), 1 (slight), 2 (mild), 3 (moderate), and 4 (severe). Part IV: 6 items, assesses dyskinesia (excessive motion) and motor fluctuations (medication is working or not), range is 0-24. Parts II-IV total scores. This is reported as the mean of the scores for each session aggregated. The smaller the overall number (closer to 0), the less disability and the greater the number (closer to 148) the greater the disability.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Baseline-MDS UPDRS 2 Total
14.1 MDS-UPDRS score on scale
Standard Deviation 2.07
12.8 MDS-UPDRS score on scale
Standard Deviation 2.07
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Post-treatment MDS UPDRS 2 Total
14.0 MDS-UPDRS score on scale
Standard Deviation 2.07
13.0 MDS-UPDRS score on scale
Standard Deviation 2.07
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Baseline-MDS UPDRS 3 Total
34.6 MDS-UPDRS score on scale
Standard Deviation 3.06
37.0 MDS-UPDRS score on scale
Standard Deviation 3.06
Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Post-treatment MDS UPDRS 3 Total
32.6 MDS-UPDRS score on scale
Standard Deviation 3.06
31.6 MDS-UPDRS score on scale
Standard Deviation 3.06

SECONDARY outcome

Timeframe: Throughout study completion, between 9 to 34 days.

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The Timed Up and Go (TUG) Test is a one-item performance test. The participant starts by sitting in a chair, then stand up, walk 3 meters, turn around, walk back, and sit down. Participants are timed in seconds. TUG is used to identify/screen elderly individuals who are prone to falls. Lower times/measured in seconds is better. The Timed Up and Go (TUG) test is scored based on the time it takes to complete the test, in seconds: \< 10 seconds: Normal \< 20 seconds: Good mobility, can walk outside alone, no walking aid needed \< 30 seconds: Walking and balance problems, cannot walk outside alone, walking aid needed So less than 10 seconds would be normal and 30 seconds or more may indicate a higher risk of falling. This is reported as the mean of the scores for each session aggregated.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
Timed Up and Go (TUG) Test
Baseline-Tug Test
10.5 seconds
Standard Error 1.0
10.4 seconds
Standard Error 1.0
Timed Up and Go (TUG) Test
Post-treatment Tug Test
10.7 seconds
Standard Error 1.0
10.9 seconds
Standard Error 1.0

SECONDARY outcome

Timeframe: Throughout study completion, between 9 to 34 days.

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The Berg Balance Scale (BBS) assesses balance via performing 14 functional activities. Each item is scored along a 5-point scale, ranging from 0 to 4. Zero indicates the lowest level of function and 4 the highest level of function. The total score is a summation or total of all items and ranges from 0 to 56. Higher scores indicate less risk of falls. A cutoff score of 45 has been traditionally identified as a useful cutoff to predict falls in those who scored below the cutoff score. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. So the closer to 0, the least function and the closer to 56, the more function a subject would have. This is reported as the mean of the scores for each session aggregated.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
Berg Balance Scale (BBS)
Post-treatment-BBS
51.4 BBS score on a scale
Standard Error 1.0
52.1 BBS score on a scale
Standard Error 1.0
Berg Balance Scale (BBS)
Baseline-BBS
50.4 BBS score on a scale
Standard Error 1.0
51.4 BBS score on a scale
Standard Error 1.0

SECONDARY outcome

Timeframe: Throughout study completion, between 9 to 34 days.

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The New Freezing of Gait Questionnaire (nFOG-Q) is a six-item questionnaire that uses a 5-point scale that ranges from 0 = absence of symptoms to 4 = most severe stage. The total score ranges from 0 to 24; higher scores (closer to 24) correspond to more severe and lower scores (closer to 0) have fewer symptoms on the New Freezing of Gait Questionnaire (nFOG-Q). To objectively assess FOG severity, Parkinson's disease (PD) subjects are asked to perform brief and standardized FOG-provoking tasks in clinical centers. Common tasks include timed-up-and-go (TUG), 180 or 360 degrees turning while walking and 360-degree turning-in-place (360Turn). This is reported as the mean of the scores for each session aggregated.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
New Freezing of Gait Questionnaire (nFOG-Q)
Baseline (nFOG-Q)
10.0 (nFOG-Q) score on a scale
Standard Error 3.11
8.7 (nFOG-Q) score on a scale
Standard Error 3.11
New Freezing of Gait Questionnaire (nFOG-Q)
Post-treatment (nFOG-Q)
8.2 (nFOG-Q) score on a scale
Standard Error 3.11
9.0 (nFOG-Q) score on a scale
Standard Error 3.11

SECONDARY outcome

Timeframe: Throughout study completion, between 9 to 34 days

Population: The subject received the PDVibe2 vibration intervention turned on session and a session with the PDVibe2 vibration intervention turned off

The Fall Efficacy Scale - International includes 16 items assessing fear of falling in different scenarios, in a community-dwelling older population. Individuals are instructed to rate each activity on a four-point Likert scale, depending on how concerned they are that they may fall when performing certain activities. Items are scored from 1 = Not at all concerned to 4 = very concerned. The total score ranges from 16 - 64. The higher the score (the closer to 64) the greater the fear of falling by the subject and the lower the score (closer to 16) the less fear of falling by the subject using the Fall Efficacy Scale - International. This is reported as the mean of the scores for each session aggregated.

Outcome measures

Outcome measures
Measure
PDVibe2 Vibration Intervention Session
n=12 Participants
The PDVibe2 vibration intervention session
No Vibration Intervention Session
n=12 Participants
The no vibration intervention session
Fall Efficacy Scale - International
Baseline- Fall Efficacy Scale
29.2 Fall Efficacy Scale score
Standard Error 2.6
8.7 Fall Efficacy Scale score
Standard Error 2.6
Fall Efficacy Scale - International
Post-treatment- Fall Efficacy Scale
28.7 Fall Efficacy Scale score
Standard Error 2.6
28.4 Fall Efficacy Scale score
Standard Error 2.8

Adverse Events

Vibration Intervention Session

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

No Vibration Intervention Session

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Vibration Intervention Session
n=12 participants at risk
The subject received the PDVibe2 vibration intervention turned on session
No Vibration Intervention Session
n=12 participants at risk
The subject received a session with the PDVibe2 vibration intervention turned off
Musculoskeletal and connective tissue disorders
Dizziness
16.7%
2/12 • Number of events 2 • During the intervention periods and the wash-out period, 21 days total.
16.7%
2/12 • Number of events 2 • During the intervention periods and the wash-out period, 21 days total.
Musculoskeletal and connective tissue disorders
Leg cramp/sore calf
16.7%
2/12 • Number of events 2 • During the intervention periods and the wash-out period, 21 days total.
8.3%
1/12 • Number of events 1 • During the intervention periods and the wash-out period, 21 days total.

Additional Information

Ingrid Pretzer-Aboff

Virginia Commonwealth University

Phone: 302-893-9504

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place